Estimated Cost of Anticancer Therapy Directed by Comprehensive Genomic Profiling in a Single-Center Study

PURPOSE: Comprehensive genomic profiling (CGP) detects several classes of genomic alterations across numerous genes simultaneously and can match more patients with genomically targeted therapies than conventional molecular profiling. The current study estimated the costs of anticancer drugs and over...

Descripción completa

Detalles Bibliográficos
Autores principales: Chawla, Anita, Janku, Filip, Wheler, Jennifer J., Miller, Vincent A., Ryan, Jason, Anhorn, Rachel, Zhou, Zhou, Signorovitch, James
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Clinical Oncology 2018
Materias:
Original Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7446484/
https://www.ncbi.nlm.nih.gov/pubmed/32913996
http://dx.doi.org/10.1200/PO.18.00074

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7446484/
https://www.ncbi.nlm.nih.gov/pubmed/32913996
http://dx.doi.org/10.1200/PO.18.00074

Ejemplares similares